✦ LIBER ✦

Avoidance of weight gain is important for oral type 2 diabetes treatments in Sweden and Germany: Patient preferences

✍ Scribed by Mohamed, A.F.; Zhang, J.; Johnson, F.R.; Lomon, I. Duprat; Malvolti, E.; Townsend, R.; Östgren, C.J.; Parhofer, K.G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB64 The Avoidance of Weight Gain is Im

✍ Mohamed, A.; Zhang, J.; Johnson, F.R.; Duprat lomon, I.; Malvoti, E.; Ostgren, C 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PDB22 SELF-MONITORING OF BLOOD GLUCOSE (

✍ S Tunis; WD Willis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PDB17 ABSOLUTE AND INCREMENTAL EFFECTS O

✍ A Shearer; A Bagust; O Schöeffski; A Liebl; A Goertz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Comparison of Preference for NovoPen® 4

✍ Harma Israël-Bultman; Jacob Hyllested-Winge; Marcin Kolaczynski; Jörg Steindorf; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 753 KB

Polypharmacy in people with Type 1 and T

✍ Bauer, S.; Nauck, M. A. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB

Irbesartan is projected to be cost and l

✍ Palmer, Andrew J.; Annemans, Lieven; Roze, Stephane; Lapuerta, Pablo; Chen, Rola 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 66 KB